Intra-Cellular Therapies
ITCI
#1335
Rank
S$18.21 B
Marketcap
$171.40
Share price
-0.02%
Change (1 day)
83.14%
Change (1 year)

Intra-Cellular Therapies (ITCI) Fails to deliver data

Key failure to deliver metrics for Intra-Cellular Therapies:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Intra-Cellular Therapies (ITCI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Intra-Cellular Therapies (ITCI) - since 2014

Volume in USD (price x number of shares), data since 2014

Intra-Cellular Therapies (ITCI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025S$0.05 M-99.78%
2024S$24.89 M-40.94%
2023S$42.15 M51.56%
2022S$27.81 M16.21%
2021S$23.93 M25.98%
2020S$18.99 M-33.46%
2019S$28.54 M2213.17%
2018S$1.23 M-95.97%
2017S$30.59 M29.42%
2016S$23.63 M-65.91%
2015S$69.33 M104.09%
2014S$33.97 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
S$0.05 MS$0.07 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.22 MS$0.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.12 MS$3.29 M๐Ÿ‡บ๐Ÿ‡ธ USA